MX2010004852A - Anthelmintic combination. - Google Patents

Anthelmintic combination.

Info

Publication number
MX2010004852A
MX2010004852A MX2010004852A MX2010004852A MX2010004852A MX 2010004852 A MX2010004852 A MX 2010004852A MX 2010004852 A MX2010004852 A MX 2010004852A MX 2010004852 A MX2010004852 A MX 2010004852A MX 2010004852 A MX2010004852 A MX 2010004852A
Authority
MX
Mexico
Prior art keywords
combination
anthelmintic combination
anthelmintic
compositions
controlling
Prior art date
Application number
MX2010004852A
Other languages
Spanish (es)
Inventor
Hyun Sun Cho
Fabiando Peterson Lopes
Alvimar Costa
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2010004852A publication Critical patent/MX2010004852A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compositions for controlling parasites, comprising a combination of ivermectin, abamectin, albendazole sulphoxide and trichlorfon and the use of such compositions in the preparation of a medicament for controlling endoparasites.
MX2010004852A 2007-11-09 2008-11-07 Anthelmintic combination. MX2010004852A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07120380 2007-11-09
PCT/EP2008/065126 WO2009060063A1 (en) 2007-11-09 2008-11-07 Anthelmintic combination

Publications (1)

Publication Number Publication Date
MX2010004852A true MX2010004852A (en) 2010-06-02

Family

ID=39059330

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004852A MX2010004852A (en) 2007-11-09 2008-11-07 Anthelmintic combination.

Country Status (7)

Country Link
CN (1) CN101848710A (en)
AR (1) AR069223A1 (en)
AU (1) AU2008324095A1 (en)
BR (1) BRPI0820260A2 (en)
MX (1) MX2010004852A (en)
WO (1) WO2009060063A1 (en)
ZA (1) ZA201002315B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2475430B1 (en) * 2009-09-07 2018-01-24 Argenta Manufacturing Limited Granulated anthelmintic preparations and delivery systems
EP2793874B1 (en) * 2011-12-20 2016-10-19 Ectin Research AB Synergistic combination comprising avermectins and a nsaid for tumor inhibition
CN102743403A (en) * 2012-06-26 2012-10-24 格特生物制药（天津）有限公司 Parasite expelling tablet for domestic animals and preparation method thereof
CN102726443B (en) * 2012-07-12 2013-11-27 中国林业科学研究院亚热带林业研究所 Ivermectin and dipterex compound pesticide
RU2699799C1 (en) * 2019-01-10 2019-09-11 Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) Antiparasitic composition and a method for use thereof for treating parasitosis of ruminant animals
CN113755610B (en) * 2021-10-08 2023-09-12 内蒙古自治区农牧业科学院 Gene for detecting sensitivity of haemonchus contortus to ivermectin and application
CN114452314A (en) * 2022-01-12 2022-05-10 河南百草元兽药有限公司 Albendazole ivermectin powder and preparation method thereof
CN114569561A (en) * 2022-03-28 2022-06-03 中牧实业股份有限公司黄冈动物药品厂 Albendazole ivermectin powder and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1069032C (en) * 1997-03-27 2001-08-01 中国农业大学 Antiparasitic medicine containing avermectin/ivermectin for animals
AU2003900505A0 (en) * 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition

Also Published As

Publication number Publication date
AR069223A1 (en) 2010-01-06
AU2008324095A1 (en) 2009-05-14
CN101848710A (en) 2010-09-29
WO2009060063A1 (en) 2009-05-14
ZA201002315B (en) 2010-11-24
BRPI0820260A2 (en) 2015-05-26

Similar Documents

Publication Publication Date Title
MX2010004852A (en) Anthelmintic combination.
MY153921A (en) Aminopyrazole derivatives
MX2009007254A (en) Tablet-in-tablet compositions.
NO20091133L (en) Use of 2-6- (3-amino-piperidin-L-yl) -3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile
EP1981527A4 (en) Thermally-targeted delivery of medicaments, including doxorubicin
IL192763A (en) Pyrimidine derivatives, compositions comprising them and use thereof for the manufacture of medicaments for the treatment of cancer
HK1128471A1 (en) Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents
HK1139854A1 (en) Fast-dissolving disintegrating film preparation having high proportion of active agent
MY153985A (en) Aminotriazole derivatives as alx agonists
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
MY153975A (en) Pyridine derivatives as s1p1/edg1 receptor modulators
MX2009011578A (en) 6-phenylpyrimidinones as pim modulators.
IL194800A0 (en) Pre-mixed, ready-to-use pharmaceutical compositions
MX2009010167A (en) Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent.
IL216176A (en) (3'-fluoro-4'-(hydroxymethyl)-5'-(methylsulfonyl)biphenyl-4-yl)-2-phenylalkyl-(1h-imidazol-4-yl)propan-2-ol derivatives and pharmaceutical compositions comprising the same
WO2010009200A3 (en) Methods for treating oral cavity infections with chlorine dioxide
MX2010001574A (en) Cannabinoid receptor ligands.
IL197232A (en) Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives, medicaments comprising them, uses thereof and processes for their preparation
WO2006136580A3 (en) 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
BRPI0910912A2 (en) Compound, prodrug, glucokinase activator, pharmaceutical agent, and, compound use
EA200900958A1 (en) DRUG NEVIRAPIN PREPARATION
WO2007133944A3 (en) Topical administration of acyclovir
MY158253A (en) Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor
BRPI0813094A2 (en) 1,2,3,4-TETRA-HYDRO PYROROLO (1,2-A) PIRAZINE-6-CARBOXAMIDES AND 2,3,4,5-TETRA HYDRO-PYROROLO derivatives (1,2-A) (1,4 ) -DIAZEPINA-7-CARBOXAMIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
CL2012002543A1 (en) Endoparasiticidal composition comprising a combination of a compound of formula (i) derived from amidoacetonitrile and abamectin; and its use for the control of endoparasites, in particular helminths.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal